EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH BCG-UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER: 36-MONTH FOLLOW-UP FROM A PHASE 3 TRIAL

被引：0

作者：

Stephen, Boorjian A.

Vikram, Narayan M.

Viraj, Master A.

Badrinath, Konety R.

Neal, Shore D.

Ashish, Kamat M.

Colin, Dinney P. N.

Trinity, Bivalacqua J.

Max, Kates R.

Jeffrey, Montgomery S.

Seth, Lerner P.

Paul, Crispen L.

Gary, Steinberg D.

Piyush, Agarwal K.

Anne, Schuckman K.

Robert, Svatek S.

Brian, Lane R.

Lawrence, Karsh, I

Marc, Bjurlin A.

Gordon, Brown A.

Yair, Lotan

Brant, Inman A.

Michael, Williams B.

Michael, Cookson S.

Sam, Chang S.

Eric, Kim H.

Alexander, Sankin, I

Michael, O'Donnell A.

Jorn, Jakobsen S.

Kristian, Juul

机构：

[1] Mayo Clin, Dept Urol, Rochester, MN USA

[2] Emory Univ, Dept Urol, Sch Med, Atlanta, GA USA

[3] Univ Minnesota, Dept Urol, Minneapolis, MN USA

[4] Allina Hlth Canc Inst, Minneapolis, MN USA

[5] Carolina Urol Res Ctr, Myrtle Beach, SC USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX USA

[7] James Buchanan Brady Urol Inst, Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA

[8] Univ Michigan, Dept Urol, Ann Arbor, MI USA

[9] Baylor Coll Med, Scott Dept Urol, Houston, TX USA

[10] Univ Florida, Dept Urol, Gainesville, FL USA

[11] Rush Univ, Dept Urol, Chicago, IL USA

[12] Univ Chicago, Sect Urol, Dept Surg, Chicago, IL USA

[13] Univ Southern Calif, Inst Urol, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[14] Univ Texas Hlth San Antonio, Dept Urol, San Antonio, TX USA

[15] Michigan State Univ, Div Urol, Spectrum Hlth, Coll Human Med, Grand Rapids, MI USA

[16] Urol Ctr Colorado, Denver, CO USA

[17] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[18] Univ N Carolina, Dept Urol, Chapel Hill, NC USA

[19] New Jersey Urol, Bloomfield, NJ USA

[20] Univ Texas Southwestern Med Ctr, Dept Urol, Dallas, TX USA

[21] Duke Univ, Div Urol, Dept Surg, Sch Med, Durham, NC USA

[22] Urol Virginia, Virginia Beach, VA USA

[23] Univ Oklahoma, Dept Urol, Hlth Sci Ctr, Oklahoma City, OK USA

[24] Vanderbilt Univ, Div Urol Oncol, Nashville, TN USA

[25] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[26] Montefiore Med Ctr, Dept Urol, Bronx, NY USA

[27] Univ Iowa, Dept Urol, Iowa City, IA USA

[28] Ferring Pharmaceut A S, Copenhagen, Denmark

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷

关键词：

D O I：

10.1016/j.urolonc.2024.01.201

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

164

引用

页码：S70 / S70

页数：1

共 50 条

[21] A phase 1/2 study of EG-70 (detalimogene voraplasmid) intravesical monotherapy for patients with BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ
Bryce, Richard
Tosone, Christine
Sullivan, James C.
Linback, Tammy
Steinberg, Gary D.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[22] AN INTERIM ANALYSIS OF A PHASE II CLINICAL STUDY OF INTRAVESICAL PHOTO DYNAMIC THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS)
Kulkarni, Girish
Richards, Kyle
Black, Peter C.
Rendon, Ricardo
Chin, Joseph
Shore, Neal
Jayram, Gautam
Kramolowsky, Eugene
Saltzstein, Daniel
Agarwal, Piyush
Belkoff, Laurence
O'Donnell, Michael
Kamat, Ashish M.
Zlotta, Alexandre
Jewett, Michael A. S.
Lamm, Donald
DeGruttola, Victor
Mandel, Arkady
Dumoulin-White, Roger J.
Kassouf, Wassim
JOURNAL OF UROLOGY, 2023, 209 : E871 - E871
[23] A phase I/II study of EG-70 (detalimogene voraplasmid) intravesical monotherapy for patients (pts) with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS)
Palou, J.
Marcq, G.
Steinberg, G.
Toscone, C.
Sullivan, J.
Linback, T.
Pruthi, R.
Bryce, R.
Brown, G.
ANNALS OF ONCOLOGY, 2024, 35 : S1165 - S1165
[24] Efficacy of two interventions on the discontinuation of benzodiazepines in long-term users: 36-month follow-up of a cluster randomised trial in primary care
Vicens, Caterina
Sempere, Ermengol
Bejarano, Ferran
Socias, Isabel
Mateu, Catalina
Fiol, Francisca
Palop, Vicente
Mengual, Marta
Folch, Silvia
Lera, Guillem
Basora, Josep
Leiva, Alfonso
BRITISH JOURNAL OF GENERAL PRACTICE, 2016, 66 (643): : E85 - E91
[25] Efficacy and safety of givosiran in patients with acute hepatic porphyria: 36-month results of the phase 3 ENVISION randomised clinical trial
Thapar, Manish
Bonkovsky, Herbert L.
Monroy, Susana
Ross, Gayle
Guillen-Navarro, Encarna
Cappellini, Maria Domenica
Minder, Anna-Elisabeth
Liu, Shangbin
Sweetser, Marianne T.
Kuter, David
JOURNAL OF HEPATOLOGY, 2022, 77 : S60 - S61
[26] EFFICACY AND SAFETY OF GIVOSIRAN IN PATIENTS WITH ACUTE HEPATIC PORPHYRIA: 36-MONTH RESULTS OF THE PHASE 3 ENVISION RANDOMIZED CLINICAL TRIAL
Thapar, Manish
Kuter, David J.
Bonkovsky, Herbert L.
Monroy, Susana
Ross, Gayle
Guillen-Navarro, Encarna
Cappellini, Maria Domenica
Minder, Anna-Elisabeth
Liu, Shangbin
Sweetser, Marianne
HEPATOLOGY, 2022, 76 : S1111 - S1112
[27] EFFICACY AND SAFETY OF GIVOSIRAN IN PATIENTS WITH ACUTE HEPATIC PORPHYRIA: 36-MONTH RESULTS OF THE PHASE 3 ENVISION RANDOMIZED CLINICAL TRIAL
Thapar, Manish
Bonkovsky, Herbert L.
Monroy, Susana
Ross, Gayle
Guillen-Navarro, Encarna
Cappellini, Maria Domenica
Minder, Anna-Elisabeth
Liu, Shangbin
Sweetser, Marianne T.
Kuter, David J.
GASTROENTEROLOGY, 2022, 162 (07) : S80 - S81
[28] EFFICACY AND SAFETY OF GIVOSIRAN IN PATIENTS WITH ACUTE HEPATIC PORPHYRIA: 36-MONTH RESULTS OF THE PHASE 3 ENVISION RANDOMIZED CLINICAL TRIAL
Deering, Robert
Thapar, Manish
Bonkovsky, Herbert
Monroy, Susana
Ross, Gayle
Guillen-Navarro, Encarna
Cappellini, Maria Domenica
Minder, Anna-Elizabeth
Liu, Shangbin
Sweetser, Marianne
Kuter, David
MUSCLE & NERVE, 2022, 66 : S75 - S76
[29] CG0070, AN ONCOLYTIC ADENOVIRUS, FOR BCG-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER (NMIBC): 12 MONTH INTERIM RESULTS FROM A MULTICENTER PHASE II TRIAL
Packiam, Vignesh T.
Barocas, Daniel A.
Chamie, Karim
Davis, Ronald L., III
Kader, A. Karim
Lamm, Donald L.
Gutheil, John
Kuan, Arthur
Steinberg, Gary D.
JOURNAL OF UROLOGY, 2018, 199 (04): : E1166 - E1166
[30] PHASE 2/3 CLINICAL RESULTS OF IL-15RAFC SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS) PATIENTS.
Chamie, Karim
Chang, Sam
Gonzalgo, Mark
Kramolowski, Eugene
Reddy, Sandeep
Soon-Shiong, Patrick
Garner, Chad
JOURNAL OF UROLOGY, 2021, 206 : E120 - E121

← 1 2 3 4 5 →